Approval · Notice of Compliance 4223 · 1996
ZITHROMAX: Notice of Compliance 4223
Issued June 24, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4223
- Date
- June 24, 1996
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for powder for oral suspension 100mg/5ml and 200mg/5ml after reconstitution
- Therapeutic class
- Antibiotic
Products in this notice
Medicinal ingredients
- AZITHROMYCIN 100 MG per 5ML
- AZITHROMYCIN 200 MG per 5ML